Skip to main content

STAQ Pharma, Inc.

Recalls

Recalls by year

A bar chart of the number of recalls naming this company by year.

Recalls by year
YearRecalls
20222
20231
20253
Download CSV

FDA Recall Ongoing Historical recordClass III

FentaNYL Citrate PF, 500mcg/50 mL (10mcg/mL) in NACL, Injection for IV use, 50 mL syringe, STAQ Pharma Inc., 14135 E 42nd Ave, Denver, Colorado, NDC 73177-0102-05.

by STAQ Pharma, Inc.

Reason
Labeling: Incorrect or Missing Lot and/or Exp Date
Published
October 22, 2025
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass III

Ketamine Hydrochloride, 50mg/5 mL (10mg/mL), Injection for IV use, 50 mL syringe, STAQ Pharma Inc., 14135 E 42nd Ave, Denver, Colorado, NDC 73177-0156-02.

by STAQ Pharma, Inc.

Reason
Labeling: Incorrect or Missing Lot and/or Exp Date
Published
October 22, 2025
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass III

Hydromorphone HCL PF, 10mg/50 mL (0.2mg/mL) in NACL, Injection for IV use, 50 mL Syringe, STAQ Pharma Inc., 14135 E 42nd Ave, Denver, Colorado, NDC 73177-0104-05.

by STAQ Pharma, Inc.

Reason
Labeling: Incorrect or Missing Lot and/or Exp Date
Published
October 22, 2025
Distribution
Nationwide

View recall →

FDA Recall Completed Historical recordClass II

ROPivacaine HCl 0.2% PF in Sodium Chloride 1,000 mg/500 mL (2 mg per mL) Injection, 500 mL bags, Rx only, STAQ Pharma Inc. 14135 E 42nd Ave, Unit 50, Denver, Colorado 80239, NDC 73177-0109-26,

by STAQ Pharma, Inc.

Reason
STAQ Pharma Inc. received consumer complaints related to leaking bags and other potential bag concerns. Upon investigation, they determine the source of the issue was with the bag manufacturer who released bags Lot # 134142-001A which had failed internal QC tests for leaks.
Published
December 13, 2023
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass I

Morphine Sulfate PF 25 mg/25mL (1 mg/mL) in NaCl, 25 mL in 30 mL Single Dose Syringe, Rx only, STAQ Pharma, Inc., Denver, CO 80239, NDC: 73177-0105-04.

by STAQ Pharma, Inc.

Reason
Labeling: Label Mix up; A limited number of syringes containing HYDROmorphone HCl PF were incorrectly labeled as Morphine Sulfate PF with lot number 21104221A
Published
February 23, 2022
Distribution
CO, OH, and TX.

View recall →

FDA Recall Terminated Historical recordClass I

HYDROmorphone HCl PF 10 mg/50 mL (0.2mg/mL) in NaCl, 50 mL in 50 mL Single Dose Syringe, Rx only, STAQ Pharma, Inc., Denver, CO 80239, NDC: 73177-0104-05.

by STAQ Pharma, Inc.

Reason
Labeling: Label Mix up; A limited number of syringes containing HYDROmorphone HCl PF were incorrectly labeled as Morphine Sulfate PF with lot number 21104221A
Published
February 23, 2022
Distribution
CO, OH, and TX.

View recall →

Showing 1–6 of 6 results

This page lists recalls that name STAQ Pharma, Inc. as the recalling firm in the official source notice. It is not a safety rating, ranking, or statement that the company acted negligently. Read the full medical disclaimer.